Hard To Treat Diseases (HTDS) Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And ... ( BELGRADE SERBIA July 1 / Hard To Trea...)

HOME >> MEDICINE >> NEWS

Hard To Treat Diseases (HTDS) Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin

Date:7/1/2009

BELGRADE, SERBIA, July 1 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS) (www.htdsmedical.com) Chief Scientist with its Slavica BioChem subsidiary, Dr. Sanja Pekovic provided updates on recent clinical trials with animal subjects in regards to the use of Ribavirin And Tiazofurin for the potential treatment of Multiple Sclerosis (MS).

Dr. Pekovic reported; "It is now well accepted that axonal injury begins at an early stage in MS, and likely accounts for clinical progression seen later in the disease course, suggesting that early, aggressive treatment is critical in order to suppress long-term disability progression. Researchers from IBISS group (a related research group) tested the effect of combined treatment with ribavirin (R) and tiazofurin (T) administrated during the effecter phase of disease.

Dr. Pekovic added: "We are hopeful, that with additional funding, we will be able to continue along this promising path, and continue researching the potential applications of a combination of ribavirin and tiazofurin in the treatment of MS."

This is a narrative report - release. A full detailed release will be posted on the company's website www.htdsmedical.com shortly.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Hard To Treat Diseases Inc that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. Hard To Treat Diseases Inc cautions you that any forward-looking information provided by or on behalf of Hard To Treat Diseases Inc is not a
'/>"/>

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Nation Takes a Big Step Toward Learning Which Medical Treatments Work Best, a Major Advance in Fixing Our Broken Health-Care System
2. The Other Cruciate Ligament: Newer Treatments for PCL Tears
3. New treatment for receding gums: No pain, lots of gain
4. Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration
5. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
6. Holistic Skin Contouring Treatment Now Offered by Renowned Surgeon - The Results Are Simply Amazing
7. U.S. Doctors Treat Heart Attack With Mans Own Stem Cells
8. Even After Death, Heart Attack Treatment May Not End
9. Measurements fail to identify TB patients who could benefit from shorter treatment course
10. Women with cystic fibrosis can have safe and successful fertility treatment
11. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases

Post Your Comments:

(Date:5/18/2013)... American Gastroenterological Association (AGA) Research Foundation is pleased ... honorees are outstanding young gastroenterologists working toward independent ... with this award, their research time will be ... future of our field. AGA is committed to ... for promising research developments and new therapies," said ...

(Date:5/18/2013)... By Dennis Thompson HealthDay Reporter , , FRIDAY, ... Association unveils the latest edition of what is considered ... over its many changes continues. "This is unprecedented, ... Dr. Jeffrey Lieberman, president-elect of the American Psychiatric Association ... is what it is. You have to evaluate it ...

(Date:5/18/2013)... The use of a smartphone application significantly ... new research presented today at Digestive Disease Week ... advance of the procedure, includes dietary restrictions and ... at strict intervals. The better the preparation, the ... and precancerous polyps in the colon. The study, ...

(Date:5/18/2013)... 2013 Assisted living and retirement ... safety and comfort of their residents. Systems Technologies ... with an effective and cost-efficient solution – VisionLink ... integrated, turnkey communications solution that helps nurses provide ... independence and privacy. , The VisionLink ...

(Date:5/18/2013)... The Communities of Distinction TV program presents ... These are the townships, villages and other small spots not ... people are friendly and neighbors are there when you need ... shares the best in both the United States and Canada. ... and film celebrity. It airs in May and will run ...

Breaking Medicine News(10 mins):Health News:AGA Research Foundation Research Scholar Awards advance the work of promising gastroenterologists 2 Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 2 Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 3 Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 4 Health News:New smartphone application improves colonoscopy preparation 2 Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2 Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3 Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2

[0] AGA Research Foundation Research Scholar Awards advance the work of promising gastroenterologists [0] Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy [0] New smartphone application improves colonoscopy preparation [0] VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities [0] Communities of Distinction TV Presents "A Place to Call Home" Segment

... a catastrophic epidemic of smoking deaths, which is expected to cause ... including one in five of all male deaths and one ... male bidi smokers lose about six years of life, female bidi ... ten years. , The findings are from the first nationally ...

... ReBuilder Medical,Technologies, Inc. (Pink Sheets: RBRM), ... for diabetic peripheral neuropathy, Molluscum,Contagiosum, and MRSA, ... year, details,are available on their Annual Report ... http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ), "The company,s growth ...

... German trial could be a breakthrough treatment in vascular ... stents haven,t worked well for blocked leg arteries, but ... balloons, which are inserted at the end of catheters ... whose balloons were coated with paclitaxel, one of the ...

... Approves Stock Repurchase Program, Raising 2008 EPS Guidance to $2.58 to $2.73 ... ... BEACH, Va., Feb. 13 AMERIGROUP,Corporation (NYSE: AGP ) today announced ... $31.1 million, or $0.57 per diluted,share, versus net income of $29.9 million, ...

... Feb. 13 Watson,Pharmaceuticals, Inc. (NYSE: WPI ... the U.S. Food and Drug Administration ("FDA"),has initiated ... regarding the duration or outcome of the inspection ... Florida manufacturing facility has,been under Official Action Indicated ...

... trauma disorder as good a marker for health status as ... People with post-traumatic stress disorder (PTSD) are as likely to ... disease risk factors, a new study suggests. , The findings, ... of Nervous and Mental Disease , come from examining the ...

India caught in catastrophic smoking epidemic ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006 Drug-Coated Balloons Keep Leg Arteries Open: Study AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities PTSD a Risk Factor for Long-Term Disease

(Date:5/17/2013)... , May 17, 2013 Sony Biotechnology Inc. ("Sony") ... 8-well strip holder and 130um sorting chip. Sony will also ... on its new SH800 Cell Sorter, the EC800 flow cytometer, ... tutorials at CYTO 2013, which will be held at the ... San Diego, California , from May 20 - ...

(Date:5/17/2013)... 17, 2013 TechAtlas Group has announced the ... landscape map for the Chronic Kidney Disease (CKD) ... companies with drugs and devices currently on the ... sequelae. (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ... hypertension - renal denervation , diabetic nephropathy ...

(Date:5/17/2013)... Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) ... new, patent-pending technologies poised to redefine how consumers receive energy, ... a business update teleconference and webcast for shareholders and the ... 4:30 PM ET. Fuse Science, Inc. CEO, ... and will be joined by Rubin Hanan ...

Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2 TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2 Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2

[0] Sony Delivers New Technology for Science to CYTO 2013 [0] TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map [0] Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd

... AMSTERDAM, September 19, 2011 Agendia, ... that a published report highlighting the development and ... was published online in Breast Cancer Research ... a part of Agendia,s Symphony™ suite of breast ...

... Laser Med Center , which specializes in treating Trigeminal ... laser device. This is a non-invasive alternative to surgery, ... Trigeminal Neuralgia is a terribly painful condition of ... (the fifth cranial nerve or CN5) is primarily a ...

Cached Medicine Technology:Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint® 2 Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint® 3 FDA Approved, Non-Invasive Laser Is A Success in Trigeminal Neuralgia Pain Treatment 2

Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint®FDA Approved, Non-Invasive Laser Is A Success in Trigeminal Neuralgia Pain Treatment

... temporary internal drainage from the ureteropelvic junction ... stricture. The segment with no sideports prevents ... preventing ingrowth of the ureteral wall to ... Intended for one-time use. CAUTION: Periodic evaluation ...

... for temporary internal drainage from the ureteropelvic ... a stricture. The segment with no sideports ... while preventing ingrowth of the ureteral wall ... packages. Intended for one-time use. CAUTION: Periodic ...

ACMI™ 4.8 Fr Closed Tip Ureteral Stents are easily inserted through the 5 Fr working port of an endoscope. Large internal lumens enhance urinary flow, promoting the kind of drainage you might o...

... Used for retrograde ... and subsequent ureteral stent ... has a radiopaque band ... to aid in fluoroscopic ...

Medicine Products:

ULTRATHANE Endoureterotomy Stent Sets C-FLEX Endoureterotomy Stent Sets 4.8 Fr Closed Tip Ureteral Stents Desilets-Hoffman Introducer Sets